MeSH D013290 - streptococcal infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016908:Gram-positive bacterial infections
D013290:
Streptococcal infections
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Erythromycin lactobionate | Erythromycin | 1985-03-28 | |||
| Erythromycin | Robimycin | 1982-01-01 | ||||
| Abbott Biotherapeutics | Clindamycin | Clindamycin | 2001-06-29 | |||
| Erythromycin lactobionate | Erythrocin | 1988-01-04 | ||||
| Alembic Pharmaceuticals | Azithromycin | Azithromycin | 2020-01-28 | |||
| Linezolid | Linezolid | 2015-12-21 | ||||
| Erythromycin | Erythromycin | 2023-08-24 | ||||
| Clindamycin | Clindamycin | 2024-04-02 | ||||
| Alkem Laboratories | Erythromycin | Erythromycin | 2022-07-13 | |||
| Linezolid | Linezolid | 2015-12-21 | ||||
| Allergan | Clindamycin | Clindamycin | 1988-06-08 | |||
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide | 2015-06-19 | ||||
| Clindamycin, Tretinoin | Clindamycin Tretinoin | 2015-06-12 | ||||
| Almirall | Clindamycin, Tretinoin | Veltin | 2010-07-16 |
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
0%0/6
Phase 3
100%62/62
Approved: 60Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use